By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) To Present Preclinical Data Highlighting Potential Of Combining Mirvetuximab Soravtansine With An Immune Checkpoint Inhibitor At SITC 2016 Annual Meeting 11/11/2016 11:45:56 AM
ImmunoGen (IMGN) Reports Financial Results For Quarter Ended September 30 And Reviews Business Highlights 10/28/2016 12:26:47 PM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Financial Results For Quarter Ended September 30 10/14/2016 12:13:28 PM
Struggling ImmunoGen (IMGN) Eliminates 17% of Workforce After Strategic Review 9/30/2016 5:46:52 AM
ImmunoGen (IMGN) Announces Departure Of Chief Development Officer 8/9/2016 11:15:38 AM
ImmunoGen (IMGN) Announces Webcasts Of Presentations At Upcoming Investor Conferences 8/5/2016 11:25:58 AM
ImmunoGen (IMGN) Reports Fourth Quarter And Fiscal Year 2016 Financial Results And Provides Quarterly Business Update 8/4/2016 12:08:03 PM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2016 Financial Results 7/22/2016 7:40:06 AM
ImmunoGen (IMGN) Announces Pricing Of $100 Million Offering Of 4.50% Convertible Senior Notes Due 2021 6/15/2016 7:43:29 AM
ImmunoGen (IMGN) Announces Proposed $100 Million Offering Of Convertible Senior Notes Due 2021 6/14/2016 8:16:36 AM
12345678910...
//-->